Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study

被引:0
作者
Arvind Ganapati
Mahasampath Gowri
Belavendra Antonisamy
Debashish Danda
机构
[1] Christian Medical College & Hospital,Department of Clinical Immunology and Rheumatology
[2] Christian Medical College,Department of Biostatistics
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Ankylosing spondylitis; Axial spondyloarthritis; DMARDs; Methotrexate; Sulfasalazine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1871 / 1879
页数:8
相关论文
共 228 条
[1]  
Möttönen T(1999)Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group Lancet Lond Engl 353 1568-1573
[2]  
Hannonen P(1997)Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet Lond Engl 350 309-318
[3]  
Leirisalo-Repo M(2011)2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis Ann Rheum Dis 70 896-904
[4]  
Nissilä M(1995)Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study Arthritis Rheum 38 618-627
[5]  
Kautiainen H(1999)Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study Arthritis Rheum 42 2325-2329
[6]  
Korpela M(1988)Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial Arthritis Rheum 31 1111-1116
[7]  
Laasonen L(2006)Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial Ann Rheum Dis 65 1147-1153
[8]  
Julkunen H(2018)A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis Int J Rheum Dis 21 308-314
[9]  
Luukkainen R(2012)Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience Int J Rheum Dis 15 526-530
[10]  
Vuori K(2017)TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis Clin Rheumatol 36 2243-2251